Discontinuation report PROSTIN F2 ALPHA
Report ID | 48996 |
Drug Identification Number | 00318736 |
Brand name | PROSTIN F2 ALPHA |
Common or Proper name | PROSTIN F2A |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DINOPROST |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRA-AMNIOTIC |
Packaging size | 1 x 1ml |
ATC code | G02AD |
ATC description | UTEROTONICS |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-09-30 |
Remaining supply date | 2018-09-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | The product discontinuation is due to low market demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-02-11 | French | Compare |
v3 | 2019-02-11 | English | Compare |
v2 | 2018-05-10 | French | Compare |
v1 | 2018-05-10 | English | Compare |
Showing 1 to 4 of 4